Gigantism is abnormally large growth due to an excess of growth hormone during childhood, before the bone growth plates have closed.
The most common cause of too much growth hormone release is a noncancerous (benign) tumor of the pituitary gland. Other causes include:
If excess growth hormone occurs after normal bone growth has stopped, the condition is known as acromegaly.
Gigantism is very rare.
The child will grow in height, as well as in the muscles and organs. This excessive growth makes the child extremely large for his or her age.
Other symptoms include:
Damage to the pituitary may lead to low levels of other hormones, including:
In pituitary tumors with well-defined borders, surgery is the treatment of choice and can cure many cases.
For situations in which surgery cannot completely remove the tumor, medication is the treatment of choice. The most effective medications are somatostatin analogs (such as octreotide or long-acting lanreotide), which reduce growth hormone release.
Dopamine agonists (bromocriptine mesylate, cabergoline) have also been used to reduce growth hormone release, but these are generally less effective. Pegvisomant, a medication that blocks the effect of growth hormone, may be used.
Radiation therapy has also been used to bring growth hormone levels to normal. However, it can take 5 - 10 years for the full effects to be seen and this almost always leads to low levels of other pituitary hormones.
Radiation has also been linked to learning disabilities, obesity, and emotional changes in children. Most experts will use radiation only if surgery and medication fail.
Pituitary surgery is usually successful in limiting growth hormone production.
Surgery and radiation can both lead to low levels of other pituitary hormones, which can cause:
Call your health care provider if your child has signs of excessive growth.
Melmed S, Kleinberg D. Pituitary masses and tumors. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR. Williams Textbook of Endocrinology. 12th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 9.
Updated by: Nancy J. Rennert, MD, Chief of Endocrinology & Diabetes, Norwalk Hospital, Associate Clinical Professor of Medicine, Yale University School of Medicine, New Haven, CT. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2013, A.D.A.M., Inc. Duplication for commercial use must be authorized in writing by ADAM Health Solutions.